
Latest Articles
SARCLISA® (isatuximab) in Clinical Practice Professor Karthik Ramasamy: Frail Case Study Review
SARCLISA® (isatuximab) in Clinical Practice Dr Sally Moore: Borderline Case Study Overview
SARCLISA® (isatuximab) in Clinical Practice Professor Karthik Ramasamy: Borderline Case Study Review

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)
Read to learn more about the burdens of uncontrolled AD.

The Hidden Impact of Cumulative Life Course Impairment (CLCI) in Dermatology: An Overview
Read to learn more about the concept of CLCI, how it manifests in atopic dermatitis and its impact on patients.

Beyfortus▼ (Nirsevimab): Help protect the unprotected
Beyfortus®▼ (nirsevimab)
%20(1).jpg)
Sanofi's Commitment to Diabetes
Supporting you with reliable and sustainable insulin supply

How to start and switch insulin: a HCP guide
A practical guide for initiating or switching patients to a new insulin
MAT-XU-2305061 (v2.0) Date of preparation: February 2024